Insider · CIK 0001553822

Yanover Paul

Reports to the SEC for 1 company · LOS ANGELES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001553822

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-06-07	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+400 sh	—	—	400
2018-06-08	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+400 sh	—	—	400
2017-09-29	ERNAErnexa Therapeutics Inc.A Award	Director	AAward	+612 sh	—	—	1,163
2017-06-30	ERNAErnexa Therapeutics Inc.A Award	Director	AAward	+551 sh	—	—	551
2017-06-08	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+400 sh	—	—	400
2016-06-03	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+32.5K sh	$0.17	+$5,513.066	172,468
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+15K sh	$0.17	+$2,488.5	187,468
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+8,497 sh	$0.17	+$1,441.941	195,965
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+5,000 sh	$0.16	+$786.5	200,965
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+1,869 sh	$0.16	+$308.198	202,834
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+900 sh	$0.17	+$149.4	203,734
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+700 sh	$0.17	+$117.6	204,434
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+500 sh	$0.17	+$82.5	204,934
2016-05-26	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+66 sh	$0.15	+$9.9	205,000
2015-06-19	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+7,900 sh	$0.25	+$1,948.93	107,900
2015-06-19	ERNAErnexa Therapeutics Inc.P Purchase	Director	PPurchase	+32.1K sh	$0.25	+$8,015.37	140,000
2015-06-05	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-06-13	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+20K sh	—	—	50,000
2012-12-14	ERNAErnexa Therapeutics Inc.G Gift	Director	GGift	+100K sh	—	—	100,000
2012-07-02	ERNAErnexa Therapeutics Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+20K sh	—	—	30,000

Recent filings

Accepted (ET)
Jun 104
Yanover Paul0001493152-19-008970
SEC(opens sec.gov)
Jun 124
Yanover Paul0001493152-18-008526
SEC(opens sec.gov)
Oct 34
Yanover Paul0001493152-17-011199
SEC(opens sec.gov)
Jul 54
NTN BUZZTIME INC0001493152-17-007511
SEC(opens sec.gov)
Jun 94
NTN BUZZTIME INC0001493152-17-006429
SEC(opens sec.gov)
Jun 64
NTN BUZZTIME INC0001493152-16-010567
SEC(opens sec.gov)
May 264
NTN BUZZTIME INC0001493152-16-010361
SEC(opens sec.gov)
Jun 194
NTN BUZZTIME INC0001019687-15-002463
SEC(opens sec.gov)
Jun 84
NTN BUZZTIME INC0001019687-15-002325
SEC(opens sec.gov)
Jun 174
NTN BUZZTIME INC0001019687-13-002373
SEC(opens sec.gov)
Dec 184
Yanover Paul0001019687-12-004569
SEC(opens sec.gov)

Companies

Ernexa Therapeutics Inc.DirectorERNA

Address

2725 LAUREL PASS

LOS ANGELES, CA, 90046